4.5 Article

Gut Microbiota and Autism: Key Concepts and Findings

Journal

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
Volume 47, Issue 2, Pages 480-489

Publisher

SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10803-016-2960-9

Keywords

Autism; Autism spectrum disorder (ASD); Regressive autism; Gastrointestinal symptoms; Microbiota; Microbiome

Funding

  1. Eli Lilly
  2. Pfizer
  3. Abbott
  4. Shire
  5. Tourette Syndrome-Center for Disease Control and Prevention
  6. Hartwell Foundation
  7. Tourette Syndrome Association

Ask authors/readers for more resources

There is an emerging body of evidence linking the intestinal microbiota with autism spectrum disorders (ASD). Studies have demonstrated differences in the composition of gut bacteria between children with ASD and controls. Certain intestinal bacteria have been observed in abundance and may be involved in the pathogenesis of ASD; including members of the Clostridium and Sutterella genus. Evidence from animal models suggest that certain microbial shifts in the gut may produce changes consistent with the clinical picture of autism, with proposed mechanisms including toxin production, aberrations in fermentation processes/products, and immunological and metabolic abnormalities. In this article, we review studies examining the relationship between intestinal bacteria and ASD, and discuss bacterial species that may be implicated and proposed mechanisms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available